BaroFold to Present at C21 BioVentures Conference.BOULDER, Colo. -- BaroFold, Inc., a bio-therapeutics company focused on developing and commercializing improved protein therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. based on its proprietary PreEMT[TM] technology, announced today that Lyndal Hesterberg, President and Chief Executive Officer, will present a corporate overview and update at the C21 BioVentures Conference. The 9th Annual C21 BioVentures: The Private Lifescience Company Conference will be held May 22-24, 2007 in Monterey, California For other uses, see Monterey (disambiguation). The City of Monterey is located on Monterey Bay along the Pacific coast in central California. As of 2005, the city population was 30,641. . Dr. Hesterberg's presentation will be May 23, 2007 at 12:00 p.m. Pacific. About BaroFold BaroFold is a fully integrated bio-therapeutics company. BaroFold's PreEMT[TM] technology enables improved, safer, proprietary protein therapeutics, providing product life-cycle extensions and creating new protein therapeutics through the use of a patented protein refolding technology. PreEMT[TM] involves the use of high hydrostatic pressure hydrostatic pressure The pressure exerted by a fluid at equilibrium at a given point within the fluid, due to the force of gravity. Hydrostatic pressure increases in proportion to depth measured from the surface because of the increasing weight of fluid to disaggregate See disaggregated. and refold Re`fold´ v. t. 1. To fold again. proteins. The protein production process incorporating high pressure can result in significant final product manufacturing savings per dose compared to conventional methods, while providing the patentable basis for a safer drug with fewer aggregates in the product formulation formulation /for·mu·la·tion/ (for?mu-la´shun) the act or product of formulating. American Law Institute Formulation . The method is simple, reliable, and is operating on an industrial scale. BaroFold is currently in development with its own proprietary protein therapeutic portfolio. In addition to advancing its own proprietary therapeutics, BaroFold is also developing select improved protein therapeutics in partnerships with other biotechnology and pharmaceutical companies. For additional information about the company, please visit http://www.barofold.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion